These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 15590123)
1. The change of beta-adrenergic system after cessation of lead exposure. Chang HR; Tsao DA; Yu HS; Ho CK Toxicology; 2005 Feb; 207(1):73-80. PubMed ID: 15590123 [TBL] [Abstract][Full Text] [Related]
2. The change of beta-adrenergic system in lead-induced hypertension. Tsao DA; Yu HS; Cheng JT; Ho CK; Chang HR Toxicol Appl Pharmacol; 2000 Apr; 164(2):127-33. PubMed ID: 10764625 [TBL] [Abstract][Full Text] [Related]
3. Beta-adrenergic receptor density and adenylate cyclase activity in lead-exposed rat brain after cessation of lead exposure. Chang HR; Tsao DA; Yu HS; Ho CK Arch Toxicol; 2005 Jan; 79(1):1-6. PubMed ID: 15502967 [TBL] [Abstract][Full Text] [Related]
4. Serial changes in myocardial beta-adrenergic receptor after experimental brain death in dogs. Sakagoshi N; Shirakura R; Nakano S; Taniguchi K; Miyamoto Y; Matsuda H J Heart Lung Transplant; 1992; 11(6):1054-8. PubMed ID: 1333798 [TBL] [Abstract][Full Text] [Related]
5. Reduced vascular beta-adrenergic receptors and catecholamine response in rats with lead induced hypertension. Chang HR; Chen SS; Tsao DA; Cheng JT; Ho CK; Yu HS Arch Toxicol; 1997; 71(12):778-81. PubMed ID: 9388011 [TBL] [Abstract][Full Text] [Related]
6. Effects of 12 mT static magnetic field on sympathetic agonist-induced hypertension in Wistar rats. Okano H; Ohkubo C Bioelectromagnetics; 2007 Jul; 28(5):369-78. PubMed ID: 17330852 [TBL] [Abstract][Full Text] [Related]
7. [Studies on the relationship between beta-adrenergic receptor density on cell wall lymphocytes, total serum catecholamine level and heart rate in patients with hyperthyroidism]. Gajek J; Zieba I; Zyśko D Pol Merkur Lekarski; 2000 Aug; 9(50):541-3. PubMed ID: 11081320 [TBL] [Abstract][Full Text] [Related]
8. [Clonidine prevents development of hypertension in N (omega)-nitro-L-arginine-treated rats]. Oktar S; Ilhan S; Aksulu HE Anadolu Kardiyol Derg; 2008 Apr; 8(2):104-10. PubMed ID: 18400629 [TBL] [Abstract][Full Text] [Related]
9. Modification of atrial natriuretic peptide system in cold-induced hypertensive rats. Yuan K; Jin X; Park WH; Kim JH; Park BH; Kim SH Regul Pept; 2009 Apr; 154(1-3):112-20. PubMed ID: 19254746 [TBL] [Abstract][Full Text] [Related]
10. Decreased aortic contractile reaction to 5-hydroxytryptamine in rats with long-term hypertension induced by lead (Pb(2+)) exposure. Zhang LF; Peng SQ; Wang S Toxicol Lett; 2009 Apr; 186(2):78-83. PubMed ID: 19167473 [TBL] [Abstract][Full Text] [Related]
11. Serum vasoactive agents in lead-treated rats. Skoczyńska A; Stojek E; Górecka H; Wojakowska A Int J Occup Med Environ Health; 2003; 16(2):169-77. PubMed ID: 12921385 [TBL] [Abstract][Full Text] [Related]
12. Hypertension induced by nitric oxide synthase inhibitor increases responsiveness of ventricular myocardium and aorta of rat tissue to adrenomedullin stimulation in vitro. Pan CS; Jiang W; Zhong GZ; Zhao J; Pang YZ; Tang CS; Qi YF Life Sci; 2005 Dec; 78(4):398-405. PubMed ID: 16212982 [TBL] [Abstract][Full Text] [Related]
13. Haemodynamic effects of lead(II) acetate, ethanol, and their combination in rats. Ungváry G; Morvai V; Szakmáry E Int Arch Occup Environ Health; 2002 Oct; 75 Suppl():S45-53. PubMed ID: 12397410 [TBL] [Abstract][Full Text] [Related]
14. [Immune mechanism of cardiac remodeling induced by antibodies against to the alpha1-adrenergic receptor]. Zhou ZH; Liao YH; Li LD; Wang B; Wei F; Wang M; Wei YM Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(9):625-9. PubMed ID: 15949362 [TBL] [Abstract][Full Text] [Related]
15. Systemic evaluation of gene expression changes in major target organs induced by atorvastatin. Kato N; Liang YQ; Ochiai Y; Jesmin S Eur J Pharmacol; 2008 Apr; 584(2-3):376-89. PubMed ID: 18295756 [TBL] [Abstract][Full Text] [Related]
16. Chronic salt loading and cardiovascular-associated changes in experimental diabetes in rats. Maeda C; Schaan B; Oliveira E; Oliveira V; De Angelis K; Irigoyen M Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):574-80. PubMed ID: 17581211 [TBL] [Abstract][Full Text] [Related]